Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis.

HOME
>
論文・技術情報
>
Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis.

アブストラクト
ジャーナル名	British journal of haematology
Pubmed追加日	2026/7/30
投稿者	Shivarov, Velizar
組織名	Department of Experimental Research, Medical University Pleven, Pleven, Bulgaria.;Department of Clinical Hematology, St. Sophia General Hospital, Sofia, Bulgaria.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/42528255/